ArticleScientific reports2025
Safety and cosmetic results of trans-submental endoscopic thyroidectomy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The increasing incidence of thyroid tumors, combined with patients' growing emphasis on cosmetic outcomes, has fueled advancements in endoscopic thyroidectomy techniques. This study aims to evaluate the safety, feasibility, and aesthetic outcomes of trans-submental endoscopic thyroidectomy (TSET), a novel approach designed to overcome the limitations of the oral vestibular route. Clinical data from 95 patients who underwent TSET at our institution between May 2022 and December 2024 were retrospectively analyzed. Inclusion criteria were benign thyroid nodules ≤ 4 cm or papillary thyroid carcinoma (PTC) ≤ 3 cm without lateral neck or distant metastasis. Surgical outcomes, complications, and patient satisfaction were systematically assessed. Of the 96 patients initially enrolled, one required conversion to open thyroidectomy due to intraoperative bleeding. The remaining 95 patients successfully completed TSET, including 48 unilateral partial thyroidectomies, 6 bilateral partial thyroidectomies, 38 lobectomies with unilateral central neck dissection (UCND), and 3 total thyroidectomies with UCND. The mean operative time was 158.3 ± 40.1 min. No permanent complications, such as recurrent laryngeal nerve (RLN) injury or hypoparathyroidism, were observed. Transient RLN palsy occurred in 2 patients and resolved with conservative management. Aesthetic outcomes were highly satisfactory, with hidden submental scars and no postoperative infections reported. During the follow-up period (mean: 14.0 ± 7.7 months), no tumor recurrence was observed. TSET is a safe and feasible surgical approach with good cosmetic results and shows promising development prospects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.